Ye Tian

4PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 21, 2023
KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway.

Wenjing Xu, Liwei Xie, Yingying Yang

|Mar 02, 2023
T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study.

Pei-Jing Li, Ming Chen, Ye Tian

|Jul 26, 2022
CXCR2 Is Essential for Radiation-Induced Intestinal Injury by Initiating Neutrophil Infiltration.

Jing Hu, Qian Ji, Fei Chen

|Mar 17, 2022
GNE-493 inhibits prostate cancer cell growth via Akt-mTOR-dependent and -independent mechanisms.

Lu Jin, Wei Zhang, Ming-Yu Yao

Pageof 1

Frequent Collaborators

1 joint publications

Bo-Xin Xue

1 joint publications

Wei Tao

1 joint publications

Jing Hu

1 joint publications

Xu Wang